Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.5206 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.9689 | 100 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.845 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.28292 | 89 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 14.357 | 100 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.1217 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 12.0278 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.1033 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 11.41 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.012 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.2003 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.3074 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 12.0981 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.4923 | 99 |